09 January 2021 : Clinical Research
Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer
Bo Zhong1ACE, Juxin Shen1AEG*, Chunyi Zhang1BDE, Guozhong Zhou2BE, Yuefang Yu1DE, E Qin1BE, Jixian Tang1DE, Dongping Wu3DE, Xiaochao Liang1BEDOI: 10.12659/MSM.924778
Med Sci Monit 2021; 27:e924778
Table 1 Patient baseline data.
| Characteristic | N=60 |
|---|---|
| Sex | |
| Male | 32 (53.3%) |
| Female | 28 (46.7%) |
| Age | 66.38±4.25 |
| Stage | |
| IIIB | 32 (53.3%) |
| IV | 28 (46.7%) |
| ECOG | |
| 0 | 18 (30%) |
| 1 | 42 (70%) |
| Pathological type | |
| Adenocarcinoma | 24 (40%) |
| Squamous cell carcinoma | 36 (60%) |